0.03Open0.05Pre Close2 Volume906 Open Interest23.00Strike Price6.00Turnover9131.34%IV25.78%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.0354Delta0.0350Gamma610.33Leverage Ratio-125.5539Theta0.0000Rho21.62Eff Leverage0.0000Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet